Foster School of Medicine and a principal investigator in the Center of Excellence for Infectious Diseases at the Texas Tech University Health Sciences Center at El Paso. An accomplished vaccine immunologist, his research, which has been funded by the National Institutes of Health (NIH) since 2002, is developing new-generation vaccines against respiratory pathogens such as influenza viruses and agents important for biodefense. Zeng holds several patent applications related to new vaccines and therapeutics against anthrax, botulism and influenza, and has served as a member of numerous grant review committees for the NIH and Department of Defense. Zeng received his bachelor's degree from Sichuan University in China, his master's degree from the Chinese Academy of Sciences, and his Ph.D. in Biochemistry from Tel Aviv University in Israel. Local News on KCBD.comNewsMore>>